List your tool

Head to head · 2026

Qureight vs Unlearn.AI

Pricing, free plans, ratings, features, pros and cons, side by side. Where one comes out ahead, we mark it.

Qureight

Imaging biomarkers for lung and heart clinical trials, from a Cambridge deep-learning lab

4.1Not listed

Visit Qureight (opens Qureight in a new tab)

Unlearn.AI

Digital twins of trial participants that shrink the control arm by about a third

4.2Not listed

Visit Unlearn.AI (opens Unlearn.AI in a new tab)

Who comes out ahead

Based only on the facts in our directory. The right pick still depends on the job you need done.

  • Lower starting price

    Not comparable

    Not comparable: Qureight does not list a price

  • Free plan

    Tie

    Neither has one

  • Higher rating

    Unlearn.AI

    4.1 against 4.2

  • Same job?

    Yes

    Both are Healthcare AI tools

Side by side

Compared onQureightUnlearn.AI
Our rating4.14.2Better
Starts atNot listedNot listed
Free planNoNo
CategoryHealthcare AIHealthcare AI
PlansSee pricingSee pricing
Key features
  • Deep-learning lung imaging biomarkers Lung8, Air8 and Fibr8
  • Glass8 and Vascul8 for vascular and parenchymal measures
  • Central reads and endpoint discovery for trials
  • Imaging data curation and quality control
  • Built for pulmonary fibrosis, hypertension and bronchiectasis trials
  • Digital twins forecasting participant outcomes
  • Control arm size reduction of around 33 percent
  • Scout for literature and regulatory search
  • Hindsight dataset exploration and SimLab scenario modelling
  • Real-time trial quality monitoring
Pros
  • Consistent measurement reduces the variability that costs trial power
  • Named biomarkers rather than a generic imaging claim
  • Focused deeply on respiratory and cardiac disease
  • Fewer control participants is an ethical gain as well as a commercial one
  • Covers planning, monitoring and analysis rather than one stage
  • Four-plus months of enrolment time saved on their figures
Cons
  • No published pricing; sold to trial sponsors
  • Biomarkers need regulatory acceptance per context of use
  • Narrow therapeutic focus by design
  • No published pricing
  • Digital twin methods need regulatory acceptance per trial context
  • A forecast substituting for an observation is an argument reviewers must accept
CompanyQureight LtdUnlearn.ai, Inc.

Prices come from each vendor's pricing page, last checked 20260814. Check the vendor before you buy.

FAQ

Questions people ask

Is Qureight better than Unlearn.AI?

In our reviews Qureight scores 4.1 and Unlearn.AI scores 4.2. The better pick depends on the job. Qureight: Imaging biomarkers for lung and heart clinical trials, from a Cambridge deep-learning lab. Unlearn.AI: Digital twins of trial participants that shrink the control arm by about a third.

Which is cheaper, Qureight or Unlearn.AI?

Qureight: see pricing. Unlearn.AI: see pricing.

Do Qureight and Unlearn.AI have free plans?

Neither lists a free plan.

More comparisons